LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Kodu・Aktsiate loetelu・Achieve Life Sciences Inc

Achieve Life Sciences Inc

Suletud

2.9 -3.01

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.83

Max

2.99

Põhinäitajad
By Trading Economics
Sissetulek	109K -13M
Kasumimarginaal	-5,421.053
Töötajad	25
EBITDA	-367K -12M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+389.93% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	6. nov 2025

Turustatistika
By TradingEconomics
Turukapital	41M 169M
Eelmine avamishind	5.91
Eelmine sulgemishind	2.9

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

2.325 / 2.64 Toetus ja vastupanu

Achieve Life Sciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. sept 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. sept 2025, 22:10 UTC

Suurimad hinnamuutused turgudel

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. sept 2025, 21:47 UTC

Tulu

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. sept 2025, 16:52 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. sept 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. sept 2025, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Rev $17.35B >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q EPS 82c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Net $782.5M >ATD.T

2. sept 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. sept 2025, 20:53 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. sept 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. sept 2025, 20:27 UTC

Tulu

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. sept 2025, 20:24 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. sept 2025, 20:18 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. sept 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. sept 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. sept 2025, 19:55 UTC

Tulu

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. sept 2025, 19:50 UTC

Omandamised, ülevõtmised, äriostud

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. sept 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. sept 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. sept 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. sept 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. sept 2025, 16:57 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Achieve Life Sciences Inc Prognoos

Hinnasiht

By TipRanks

389.93% tõus

12 kuu keskmine prognoos

Keskmine 14.6 USD 389.93%

Kõrge 20 USD

Madal 10 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Achieve Life Sciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Achieve Life Sciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.325 / 2.64Toetus ja vastupanu

Recent bullish events outweigh bearish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.